MYUNGMOON Pharm co.,Ltd (KRX:017180)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,286.00
+90.00 (7.53%)
Sep 1, 2026, 3:30 PM KST

MYUNGMOON Pharm co.,Ltd Revenue

MYUNGMOON Pharm co.,Ltd had revenue of 51.21B KRW in the quarter ending June 30, 2026, with 5.03% growth. This brings the company's revenue in the last twelve months to 199.82B, up 4.75% year-over-year. In the year 2025, MYUNGMOON Pharm co.,Ltd had annual revenue of 195.25B with 4.72% growth.

Revenue (ttm)
199.82B
Revenue Growth
+4.75%
P/S Ratio
0.22
Revenue / Employee
686.68M
Employees
291
Market Cap
42.99B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025195.25B8.80B4.72%
Dec 31, 2024186.44B16.88B9.95%
Dec 31, 2023169.57B17.43B11.46%
Dec 31, 2022152.13B14.38B10.43%
Dec 31, 2021137.76B9.91B7.75%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Jeil Pharma Holdings630.89B
Ildong Holdings607.65B
HANDOK560.89B
HLB Pharmaceutical251.95B
Kukje Pharma181.27B
CKD Bio159.93B
Yuyu Pharma144.37B
CMG Pharmaceutical115.71B
Revenue Rankings